Webinar
/
March 14, 2025

Live Sleep Q&A with Dr. Dimitri Gavriloff

Webinar
/
This is some text inside of a div block.

Join Dr. Dimitri Gavriloff, Sleep Medicine Specialist and Clinical Psychologist, for a live sleep Q&A this World Sleep Day.

Are you struggling with where to signpost the people you support who have sleep problems? Do you want to learn more about sleep and its impact on mental and physical health? Join Dr. Dimitri Gavriloff for a live Q&A focused on the importance of good sleep health and how to support those with insomnia. In this interactive session, we are likely to explore:

  • The science of sleep and its impact on physical and mental health
  • Strategies for assessing and managing insomnia
  • The latest evidence-based treatments including how to access digital CBT for insomnia
    ‍

Designed for anyone in Scotland who supports people with poor sleep or insomnia, this webinar will provide you with practical tools to help patients or clients achieve better sleep without over-reliance on medication.

Register here.

Copy Link

Watch the replay

Here’s our latest

How DTx Will Set the Standard for Evidence in Digital Health: A Presentation from DTx West

DTx might be the future of mental health care. But only if companies prioritize high-quality research above quick turnaround.

Webinar
A Patient-First Perspective on Digital Therapeutics: A Presentation from DTx West

Two employees speak about the life-changing experience of using Sleepio and Daylight, digital therapeutics for poor sleep and worry and anxiety.

Webinar
Mental health equity: barriers and solutions

Dr. McClendon, an expert on how racism shapes mental health disparities, discusses how employers can address stigma, equitable access, and the social determinants of health.

Webinar

During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.

1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.

DOC-3046 Effective 11/2023